Literature DB >> 11817610

Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice.

Dirk Wernicke1, Claudia Schulze-Westhoff, Rolf Bräuer, Peter Petrow, Josef Zacher, Steffen Gay, Erika Gromnica-Ihle.   

Abstract

OBJECTIVE: To study the expression of collagenase 3 (matrix metalloproteinase 13 [MMP-13]) and collagenase 1 (MMP-1) in synovial fibroblasts from patients with rheumatoid arthritis (RA) when cultured within 3-dimensional collagen gels or coimplanted with normal cartilage in immunodeficient NOD/SCID mice.
METHODS: Messenger RNA (mRNA) and protein expression of collagenase 3 and collagenase 1 were characterized in synovial and skin fibroblasts by Northern blot and Western blot analysis. The mRNA expression of both collagenases in cell-cartilage implants in NOD/SCID mice was investigated by in situ hybridization in combination with immunohistochemistry of human fibroblasts.
RESULTS: Synovial fibroblasts coimplanted with normal cartilage in NOD/SCID mice deeply invaded adjacent cartilage tissue. In this in vivo system of cartilage destruction, collagenase 3 mRNA was induced in synovial fibroblasts at sites of cartilage erosion, while the expression of collagenase 1 mRNA could not be detected. Culture of synovial fibroblasts within 3-dimensional collagen gels was associated with a marked increase in collagenase 3 mRNA expression and proenzyme production. This stimulatory effect was 1 order of magnitude higher in comparison with a 2-4-fold increase upon treatment with interleukin-1beta or tumor necrosis factor a. In contrast, mRNA expression and proenzyme production of collagenase 1 were increased strongly, and to a similar extent, either by contact with 3-dimensional collagen or by proinflammatory cytokines.
CONCLUSION: The expression of collagenase 3, in contrast to that of collagenase 1, is preferentially stimulated in synovial fibroblasts by 3-dimensional collagen rather than by proinflammatory cytokines. The induction of collagenase 3 by cell-matrix interactions represents a potential mechanism contributing to the invasive phenotype of synovial fibroblasts at sites of synovial invasion into cartilage in RA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11817610     DOI: 10.1002/1529-0131(200201)46:1<64::AID-ART10069>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

Review 1.  MMPs and rheumatoid synovial fibroblasts: Siamese twins in joint destruction?

Authors:  U Müller-Ladner; S Gay
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Functional significance of nerve growth factor and its receptor (TrkA) in inflammatory arthritis.

Authors:  Smriti K Raychaudhuri; Siba P Raychaudhuri
Journal:  Arthritis Res Ther       Date:  2010-06-28       Impact factor: 5.156

Review 3.  [Methotrexate as combination partner of TNF inhibitors and tocilizumab: what is reasonable from an immunological viewpoint?].

Authors:  T Witte
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

4.  Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis.

Authors:  Jin Su; Jiangtian Yu; Tingting Ren; Wei Zhang; Yuanqiang Zhang; Xinping Liu; Tiezheng Sun; Houshan Lu; Keiji Miyazawa; Libo Yao
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

5.  Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis.

Authors:  Uta Schurigt; Nadine Stopfel; Marion Hückel; Christina Pfirschke; Bernd Wiederanders; Rolf Bräuer
Journal:  Arthritis Res Ther       Date:  2004-12-10       Impact factor: 5.156

Review 6.  Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?

Authors:  Torsten Witte
Journal:  Clin Rheumatol       Date:  2015-01-22       Impact factor: 2.980

7.  Matrix metalloproteinase-13 refines pathological staging of precancerous colorectal lesions.

Authors:  Anna-Katharina Wernicke; Yuri Churin; Diana Sheridan; Anita Windhorst; Annette Tschuschner; Stefan Gattenlöhner; Martin Roderfeld; Elke Roeb
Journal:  Oncotarget       Date:  2016-11-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.